Form 4: Elevance CFO Mark Kaye Sells Shares for Tax Obligations

Elevance Health's EVP & CFO, Mark Kaye, disposed of 2,895 shares of common stock at $340.24 per share to cover tax liabilities from restricted stock vesting.

Summary

• Mark Kaye, Executive Vice President and Chief Financial Officer of Elevance Health, Inc. (ELV), reported a disposition of 2,895 shares of common stock.
• The transaction occurred on October 2, 2025, with the shares valued at $340.24 each.
• This disposition was specifically for the payment of tax liability incident to the vesting of previously granted restricted stock.
• Following this transaction, Kaye directly beneficially owns 16,082 shares of Elevance Health common stock.
• The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale for tax purposes.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction related to executive compensation (tax withholding upon restricted stock vesting) and does not reflect a discretionary buy or sell decision based on the executive's view of the company's prospects.

Positives

• The underlying event for the share disposition is the vesting of previously granted restricted stock, which represents a realized compensation benefit for the executive.

Negatives

• A reduction of 2,895 shares in direct beneficial ownership by a key executive, although for tax purposes, slightly decreases their direct equity stake in the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine event related to executive compensation within the healthcare industry, specifically the vesting of restricted stock and subsequent tax withholding. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary insider transaction for tax purposes, not indicative of a change in company fundamentals or executive confidence.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Elevance Health, ELV, Mark Kaye, Insider Transaction, Form 4, Restricted Stock, Tax Withholding, Executive Compensation, Healthcare